| Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612) |
|---|
| 05/03/2005 | CA2133337C Compounds useful for treating allergic or inflammatory diseases |
| 04/28/2005 | WO2005037257A2 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 04/28/2005 | US20050090555 Compound for the treatment of metabolic disorders |
| 04/28/2005 | US20050090487 Cardiovascular disorders; antiinflammatory agents |
| 04/28/2005 | US20050090398 Aryl ketone derivatives containing tetrazole moieties such as 5-cyclopropyl-4-{2,4-dichloro-3-[(1H-tetrazol-1-yl)methyl]benzoyl}isoxazole; good effect as a selective herbicide for paddy rice |
| 04/28/2005 | CA2542723A1 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 04/27/2005 | EP1525186A1 Inhibitors of hcv ns5b polymerase |
| 04/27/2005 | EP1525185A1 Acetylamino benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
| 04/27/2005 | EP1525183A1 Inhibitors of hcv ns5b polymerase |
| 04/27/2005 | EP1040098B1 Integrin receptor antagonists |
| 04/27/2005 | EP0994853B1 A monoether of probucol and methods for the inhibition of the expression of vcam-1 |
| 04/27/2005 | CN1198607C Composition for treating or preventing glomerulopathy |
| 04/26/2005 | US6884892 Production methods of epoxytriazole derivative and intermediate therefor |
| 04/21/2005 | WO2005035484A1 Process for production of 1-aryl-5-(trifluoromethyl)-1h- tetrazoles |
| 04/21/2005 | WO2005014525A3 Bi-aryl compound having immunosuppressive activity |
| 04/21/2005 | WO2005011646A3 Nitrooxy derivatives of losartan, valsatan, candesartan, telmisartan, eprosartan and olmesartan as angiotensin-ii receptor blockers for the treatment of cardiovascular diseases |
| 04/21/2005 | US20050085667 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
| 04/21/2005 | US20050085541 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
| 04/21/2005 | US20050085512 Amides that inhibit vanilloid receptor subtype 1 (VR1) receptor |
| 04/21/2005 | US20050084463 Antiinflammatory, antiarthritic agents, analgesics for pain caused by diabetic assoicated conditions, pneumoconiosis, angina, menstruation or cancer |
| 04/20/2005 | EP1524263A1 prodrugs containing cycloalkene derivatives |
| 04/20/2005 | EP1523475A1 Heterocyclically substituted benzoylureas, method for their production and their use as medicaments |
| 04/20/2005 | CN1608055A Compounds for the treatment of metabolic disorders |
| 04/19/2005 | US6881727 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
| 04/14/2005 | WO2005033097A1 P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same |
| 04/14/2005 | WO2005007099A3 Pkb inhibitors as anti-tumor agents |
| 04/14/2005 | US20050080119 Diaminopropionic acid derivatives |
| 04/14/2005 | CA2582437A1 Dihydroporphine derivatives, processes for their preparation, and pharmaceutical compositions containing them |
| 04/13/2005 | EP1521733A1 Modulators of the glucocorticoid receptor |
| 04/13/2005 | CN1196702C Bicyclic polyaminoacid metal complexes, method for preparing same and use in medical imaging |
| 04/12/2005 | US6878743 Controlling apoptosis; central nervous system disorders |
| 04/12/2005 | US6878739 Composition for treating or preventing glomerulopathy |
| 04/07/2005 | WO2005030736A1 Derivatives of 1,3-diones having a herbicidal activity |
| 04/07/2005 | WO2005030705A1 Inhibitors of histone deacetylase |
| 04/07/2005 | WO2005030704A1 Inhibitors of histone deacetylase |
| 04/07/2005 | WO2005019147A3 Pesticidally active phenol derivatives |
| 04/07/2005 | CA2540355A1 Phenylene derivative having tetrazole ring or thiazolidinedione ring |
| 04/07/2005 | CA2539744A1 Derivatives of 1,3-diones having a herbicidal activity |
| 04/07/2005 | CA2539117A1 Inhibitors of histone deacetylase |
| 04/06/2005 | CN1195745C Antiviral macrocyclic compounds |
| 04/06/2005 | CN1195741C Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same |
| 04/06/2005 | CN1195733C Method for preparation of aryl alkyl hydrogen peroxide |
| 04/05/2005 | US6875884 Urea derivatives as inhibitors for CCR-3 receptor |
| 04/05/2005 | US6875760 Glucagon antagonists/inverse agonists |
| 03/31/2005 | WO2004098591A3 Inhibitors of glutaminyl cyclase and their use in the treatment of neurological diseases |
| 03/31/2005 | US20050070582 For example,1-{[2-(3,5-dimethylphenoxy)-5-nitrophenyl]sulfonyl}-4-ethylpiperazine or 1-{[2-(3,5-dichlorophenoxy)-5-nitrophenyl]sulfonyl}piperazine; for the treatment of asthma, atopic dermatitis, allergic rhinitis and other inflammatory/immunological disorders |
| 03/31/2005 | US20050070539 Such as 1-(4-{4-[2-(cyclopropylmethyl-amino)-5-nitro-benzoyl]-piperazin-1-yl}-3-fluoro- phenyl)-ethanone for treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia, attention deficit disorders, or Alzheimer's disease |
| 03/31/2005 | US20050070439 Tetrazoyl oxime derivative and agricultural chemical containing the same as active ingredient |
| 03/30/2005 | CN1602191A Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 03/29/2005 | US6872714 Methods to modulate conditions mediated by the CXCR4 receptor |
| 03/24/2005 | WO2004094391A3 Process for the preparation of valsartan and intermediates thereof |
| 03/24/2005 | WO2004071426A3 Compounds for the treatment of viral infection |
| 03/24/2005 | US20050065188 Aryl or heteroaryl amide compounds |
| 03/23/2005 | EP1515709A2 Use of an alpha2delta ligand such as gabapentin or pregabalin for treating attention deficit hyperactivity disorder |
| 03/23/2005 | EP1381392A4 Synthetic catalyst for selective cleavage of protein and method for selective cleavage of protein using the same |
| 03/23/2005 | CN1193788C Beta 2-adrenergic receptor agonist |
| 03/22/2005 | US6869970 Valsartan; hypotensive agents, cardiovascular disorders, anticholesterol agents, antilipemic agents |
| 03/22/2005 | CA2225250C Bicyclic amino derivatives and pgd2 antagonist containing the same |
| 03/17/2005 | WO2005023786A1 Water-soluble tetrazolium compounds |
| 03/17/2005 | WO2005023785A1 Process for producing 2'-(1h-tetrazol-5-yl)biphenyl-4-carbaldehyde |
| 03/17/2005 | WO2005023261A1 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 03/17/2005 | WO2005023260A1 1- (2-amino-benzol) -piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 03/17/2005 | US20050059827 Process for the preparation of valsartan and intermediates thereof |
| 03/17/2005 | US20050059810 Dibenzylamine compound and medicinal use thereof |
| 03/17/2005 | US20050059668 Substituted acylpiperazine derivatives |
| 03/17/2005 | US20050059651 Lactam derivatives as antagonists for human 11cby receptors |
| 03/17/2005 | US20050059611 such as 3-{4-[1-(4-Cyclohex-1-enylphenyl)-3-(3,5-dichlorophenyl)ureidomethyl]benzoylamino}-2,2-difluoropropionic acid), used for treatment and/or prevention of hyperglycemia, diabetes, lipid metabolism disorders and obesity |
| 03/17/2005 | CA2538135A1 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 03/17/2005 | CA2537292A1 1- (2-amino-benzol) -piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 03/17/2005 | CA2537252A1 Cyclohexyl prostaglandin analogs as ep4-receptor agonists |
| 03/17/2005 | CA2532211A1 Water-soluble tetrazolium compounds |
| 03/16/2005 | EP1514867A2 Substituted phenyl derivatives, their preparation and use |
| 03/16/2005 | EP1311476B1 Aza-amino acid derivatives (factor x a?-inhibitors 15) |
| 03/16/2005 | CN1596247A Lactam derivatives as antagonists for human 11CBY receptors |
| 03/16/2005 | CN1596240A Chalcone derivatives and their use to treat diseases |
| 03/16/2005 | CN1193010C Heterocyclonitrogen heteroethane derivant with antiviral activity |
| 03/10/2005 | WO2005021535A2 A method of removing the triphenylmethane protecting group |
| 03/10/2005 | WO2005021508A1 Phenyl or pyridyl amide compounds as prostaglandin e2 antagonists |
| 03/10/2005 | WO2005020921A2 C-kit modulators and methods of use |
| 03/10/2005 | WO2005020899A2 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity |
| 03/10/2005 | WO2004012733A9 Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy |
| 03/10/2005 | US20050054706 N-substituted pyrroles, pyrazoles, imidazoles, triazoles and tetrazoles used for treating and preventing cancer, inflammation, autoimmune diseases, respiratory system disorders, septic shock, pain, preterm labor, as dietetics and sexual disorders, and disorders associated with MAP kinases |
| 03/10/2005 | US20050054639 Viricide against human t-cell leukemia/lymphoma virus infections |
| 03/10/2005 | US20050054626 Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity |
| 03/10/2005 | CA2536781A1 A method of removing the triphenylmethane protecting group |
| 03/09/2005 | EP1511739A1 Polymorphs of valsartan |
| 03/08/2005 | US6864380 Antiinflammatory agents; asthma; antiallergens; autoimmune diseases; antiarthritic agents |
| 03/08/2005 | US6864219 Substituted aryl ketones |
| 03/03/2005 | WO2005019211A2 Biaryl heterocyclic compounds and methods of making and using the same |
| 03/03/2005 | WO2005019204A1 A process for the preparation of cilostazol and of the intermediates thereof |
| 03/03/2005 | WO2005019167A2 Melanin concentrating hormone receptor antagonist |
| 03/03/2005 | WO2005019147A2 Pesticidally active phenol derivatives |
| 03/03/2005 | CA2533112A1 Melanin concentrating hormone receptor antagonist |
| 03/03/2005 | CA2528089A1 Biaryl heterocyclic compounds and methods of making and using the same |
| 03/02/2005 | EP1509509A1 Glucagon antagonists/inverse agonists |
| 03/02/2005 | EP1509254A1 New agents for magnetic imaging method |
| 03/01/2005 | US6861043 Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes |
| 02/24/2005 | US20050043388 Therapy, prevention of metabolism disorders; insulin resistance; antidiabetic agents; hypoglycemic agents; anticholesterol agents; obesity; polycystic ovarian syndrome |
| 02/24/2005 | US20050043366 Antiinflamamtory agents; immunology disorders; autoimmune diseases; antiallergens; aids viricides; antiarthritic agents; muscular disorders; Parkinson's disease; Alzheimer's disease; kidney damage |
| 02/24/2005 | US20050043317 Biaryl heterocyclic compounds and methods of making and using the same |